Close Menu

drug development

The data, analyzed from biological samples donated by GlaxoSmithKline, is available on SAEC's website for free, and the group plans to publish the associations later this year. However, an SAEC official said "it would be preliminary to develop a meaningful diagnostic chip off this data."

In an online commentary in CMAJ, an OICR official argues that if Canada's support of personalized medicine can't compete with other regions, the country will lose commercialization opportunities.

In a talk at the AAAS meeting in Chicago, Stanford University bioengineer Drew Endy said that the US needs a national initiative to support and encourage synthetic biology.

The patent, called “Fragment Complementation Assays for G Protein-Coupled Receptors and Their Signaling Pathways,” solidifies Odyssey’s position in complex-based assays, and adds depth to its IP coverage in these two areas, an Odyssey official told CBA News this week.

Scientists should “be very aware” of the “limitations” of bioluminescent reporters, and contemplate running control assays before interpreting data from high-throughput screens, NCGC researchers said.

Affy aims to target downstream genomic-analysis markets with the products gained through its acquisitions of Panomics and True Materials last year, roll out new genotyping assays on its GeneTitan array platform, and consolidate its manufacturing facilities.

Researchers from the National Institutes of Health's Chemical Genomics Center warn that the firefly luciferase enzyme may show enhanced activity with some compounds — potentially leading to false positive results.

Christian Johansson, Gov. Martin O'Malley, Ambrose Schwallie, Jonathan Fleming, Doug Cole, Jean George, Christopher Schaber, Paul Alivisatos, Steve Chu, President Barack Obama, Jay Keasling, Greg Kessler, Jeffrey New

scientists may be years away from developing genomics-based medical treatments and therapies, but the hype surrounding the news that rese

Pages

The Centers for Disease Control and Prevention estimates more people get sick and die from drug-resistant germs than previously thought, the Washington Post reports.

According to the Associated Press, three universities and a healthcare institution are sharing a gift of $1 billion.

New rules seek to limit the type of scientific and medical research that can be used to guide public health regulations, the New York Times reports.

In Nature this week: FreeHi-C approach simulates Hi-C data from interacting genome fragments, and more.